The Surprising Buy Case For Aviva plc

Royston Wild looks at a little-known share price catalyst for Aviva plc (LON: AV).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at why I believe the firm’s turnaround strategy should continue to drive stock prices in Aviva (LSE: AV) (NYSE: AV.US) higher.

Restructuring drive set to keep on delivering

Shares in insurance giant Aviva have stampeded higher since the summer, advancing almost a third from the end of June and recently topping out at their loftiest since July 2011 above 430p. This has caused many to question whether the insurance giant is looking seriously overbought given the early stage of its turnaround story. Still, in my opinion the stock has much more room to fire higher — indeed, just this week Société Générale slapped a 560p price target on the company.

Management has proved extremely adept in meeting all of the major targets laid out as part of its restructuring drive. These achievements helped Aviva drive down operating expenses by an impressive 9% in January-June, to £1.53bn, an instrumental factor in pushing operating profit 5% higher to just over £1bn.

The life insurance leviathan plans to strip £400m worth of costs out of the machine per annum, and has said that future savings exercises are likely to be “allocated towards strategic initiatives including digital and automation”.

On top of this, Aviva is also making promising progress in streamlining the business through selective disposals. Indeed, just last week the firm announced that it had sold its Aviva USA life and annuities business to Athene Holding for $2.6bn, some $800m more than had been anticipated back in December.

The deal should help the company realise its aim of cutting its internal debt pile by an additional £300m over the next two years, as well as prune its external leverage ratio closer to 40% in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in Aviva.

More on Investing Articles

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »

Investing Articles

Here’s how investors could aim for a £6,531 annual passive income from £11,000 of Aviva shares

As a stock’s yield rises when its price falls, I'm not bothered by Aviva shares’ apparent inability to break the…

Read more »